- Achieve Life Sciences press release (ACHV): Q1 GAAP EPS of -$0.19 beats by $0.11.
- As of March 31, 2026, the Company’s cash, cash equivalents, and marketable securities were $29.3 million, not including estimated net proceeds of approximately $168.6 million from the private placement, after deducting estimated agent fees and other expenses.
Achieve Life Sciences GAAP EPS of -$0.19 beats by $0.11 (ACHV:NASDAQ)
